NewsVenture Capital25/03/2021
Leyden Labs’ Unconventional Approach to Pandemic Preparedness with Intranasal Medicine
GV →GV discussed Leyden Labs’ launch financing and the author’s appointment to its board. No round total is attributed to GV.
GV discussed Leyden Labs’ launch financing and the author’s appointment to its board. No round total is attributed to GV.